TEST BANK x#
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
x# x# x# x# x# x# x#
Author: Teri Moser Woo and Wendy L. Wright
x# x# x# x# x# x# x#
, TABLE OF CONTENT
x# x#
Chapter 1. x# x# The Role of the Advanced Practice Nurse as Prescriber .................................................................. 4
x# x# x# x# x# x# x# x#
Chapter 2. x# x# Review of Basic Principles of Pharmacology ................................................................................... 5
x# x# x# x# x#
Chapter 3. x# x# Rational Drug Selection ................................................................................................................... 11
x# x#
Chapter 4. x# x# Legal and Professional Issues in Prescribing .................................................................................. 14
x# x# x# x# x#
Chapter 5. x# x# Adverse Drug Reactions ................................................................................................................... 16
x# x#
Chapter 6. x# x# An Introduction to Pharmacogenomics ............................................................................................ 19
x# x# x#
Chapter 7. x# x# Nutrition and Nutraceuticals............................................................................................................. 22
x# x#
Chapter 8. x# x# Herbal Therapies ............................................................................................................................... 28
x#
Chapter 9. Cannabis ............................................................................................................................................ 31
x# x#
Chapter 10.x# x# Pharmacoeconomics ........................................................................................................................ 35
Chapter 11.x# x# Drugs Affecting the Autonomic Nervous System ......................................................................... 38
x# x# x# x# x#
Chapter 12.x# x# Drugs Affecting the Central Nervous System ............................................................................... 45
x# x# x# x# x#
Chapter 13.x# x# Drugs Affecting the Cardiovascular and Renal Systems .............................................................. 53
x# x# x# x# x# x#
Chapter 14.x# x# Drugs Affecting the Respiratory System ....................................................................................... 61
x# x# x# x#
Chapter 15. Drugs Affecting the Hematological System .................................................................................. 65
x# x# x# x# x# x#
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ....................................... 69
x# x# x# x# x# x# x# x# x#
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ........................................................... 75
x# x# x# x# x# x# x#
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................ 77
x# x# x# x# x# x#
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............... 80
x# x# x# x# x# x# x# x# x# x# x#
Chapter 20.x# x# Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs......................... 83
x# x# x# x# x# x# x# x# x#
Chapter 21.x# x# Drugs Affecting the Reproductive System .................................................................................... 86
x# x# x# x#
Chapter 22.x# x# Drugs Affecting the Bones and Joints ........................................................................................... 92
x# x# x# x# x#
Chapter 23.x# x# Drugs Affecting the Integumentary System .................................................................................. 96
x# x# x# x#
Chapter 24.x# x# Drugs Used to Treat Bacterial Infections .................................................................................... 101
x# x# x# x# x#
Chapter 25.x# x# Drugs Used to Treat Viral, Fungal, and Protozoal Infections .................................................... 105
x# x# x# x# x# x# x# x#
Chapter 26.x# x# Drugs Used to Treat Inflammatory Processes ............................................................................. 108
x# x# x# x# x#
Chapter 27.x# x# Drugs Used to Treat Eye and Ear Disorders ............................................................................... 111
x# x# x# x# x# x# x#
Chapter 28.x# x# Anemia .......................................................................................................................................... 113
Chapter 29.x# x# Anxiety and Depression ............................................................................................................... 116
x# x#
Chapter 30.x# x# Attention Deficit-Hyperactivity Disorder .................................................................................... 120
x# x#
Chapter 31.x# x# Asthma and Allergy ..................................................................................................................... 122
x# x#
Chapter 32.x# x# Chronic Obstructive Pulmonary Disease ..................................................................................... 125
x# x# x#
Chapter 33.x# x# Contraception ................................................................................................................................ 127
Chapter 34.x# x# COVID-19: Acute and Chronic ................................................................................................... 130
x# x# x#
Chapter 35.x# x# Dermatological Conditions ........................................................................................................... 134
x#
Chapter 36. Diabetes Management .................................................................................................................. 138
x# x# x#
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease .................................................................... 146
x# x# x# x# x# x# x#
Chapter 38. Headaches ..................................................................................................................................... 149
x# x#
Chapter 39. Heart Failure ................................................................................................................................. 153
x# x# x#
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome.......................................................... 158
x# x# x# x# x# x# x#
Chapter 41. Menopausal Hormone Therapy .................................................................................................... 161
x# x# x# x#
,Chapter 42. Hyperlipidemia.............................................................................................................................. 164
x# x#
Chapter 43. Hypertension ................................................................................................................................. 169
x# x#
Chapter 44. Hyperthyroidism and Hypothyroidism ......................................................................................... 174
x# x# x# x#
Chapter 45. Obesity .......................................................................................................................................... 177
x# x#
Chapter 46. Pain Management: Acute and Chronic Pain................................................................................ 181
x# x# x# x# x# x# x#
Chapter 47. Pneumonia..................................................................................................................................... 185
x# x#
Chapter 48. Sexually Transmitted Diseases and Vaginitis .............................................................................. 187
x# x# x# x# x# x#
Chapter 49. Substance Use Disorders .............................................................................................................. 190
x# x# x# x#
Chapter 50. Tuberculosis .................................................................................................................................. 195
x# x#
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...... 197
x# x# x# x# x# x# x# x# x# x# x# x#
Chapter 52. Urinary Tract Infections ............................................................................................................... 200
x# x# x# x#
Chapter 53. Women as Patients ....................................................................................................................... 203
x# x# x# x#
Chapter 54. Men as Patients............................................................................................................................. 207
x# x# x# x#
Chapter 55. Pediatric Patients .......................................................................................................................... 209
x# x# x#
Chapter 57. Geriatric Patients .......................................................................................................................... 213
x# x# x#
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 x# x# x# x# Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
x# x# x# x# x# x# x# x# x# x#
MULTIPLE CHOICE x#
1. Nurse practitioner prescriptive authority is regulated by:
x# x# x# x# x# x#
A. The National Council of State Boards of Nursing
x# x# x# x# x# x# x#
B. The U.S. Drug Enforcement Administration
x# x# x# x#
C. The State Board of Nursing for each state
x# x# x# x# x# x# x#
D. The State Board of Pharmacy
x# x# x# x#
ANS: x # C PTS: x # x # 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescrib
x# x# x# x# x# x# x# x# x# x# x# x# x#
er include:
x#
A. Nurses know more about pharmacology than other prescribers because they take
x# x# x# x# x# x# x# x# x# x# x#
it both in their basic nursing program and in their APRN program.
x# x# x# x# x# x# x# x# x# x# x#
B. Nurses care for the patient from a holistic approach and include the patient i
x# x# x# x# x# x# x# x# x# x# x# x# x#
n decision-making regarding their care.
x# x# x# x#
C. APRNs are less likely to prescribe narcotics and other controlled substances.
x# x# x# x# x# x# x# x# x# x#
D. APRNs are able to prescribe independently in all states, whereas a physician’
x# x# x# x# x# x# x# x# x# x# x#
s assistant needs to have a physician supervising their practice.
x# x# x# x# x# x# x# x# x#
ANS: x # B PTS: x # x # 1
3. Clinical judgment in prescribing includes:
x# x# x# x#
A. Factoring in the cost to the patient of the medication prescribed
x# x# x# x# x# x# x# x# x# x#
B. Always prescribing the newest medication available for the disease process
x# x# x# x# x# x# x# x# x#
C. Handing out drug samples to poor patients
x# x# x# x# x# x#
D. Prescribing all generic medications to cut costs x# x# x# x# x# x#
ANS: x # A PTS: x # x # 1
4. The process for choosing an effective drug for a disorder includes:
x# x# x# x# x# x# x# x# x# x#
A. Asking the patient what drug they think would work best for them
x# x# x# x# x# x# x# x# x# x# x#
B. Consulting nationally recognized guidelines for disease management
x# x# x# x# x# x#
C. Prescribing medications that are available as samples before writing a prescription
x# x# x# x# x# x# x# x# x# x#
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
x# x# x# x# x# x# x#
ANS: x # B PTS: x # x # 1
5. Nonintentional nonadherence of drug therapy may occur due to:
x# x# x# x# x# x# x# x#
A. Belief that medication does not work
x# x# x# x# x#
B. Adverse drug reactions x# x#
C. Chronic conditions that require daily therapy
x# x# x# x# x#
D. Forgetfulness or distraction x# x#
ANS: x # D PTS: x # x # 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
x# x# x# x# x# x# x#
Author: Teri Moser Woo and Wendy L. Wright
x# x# x# x# x# x# x#
, TABLE OF CONTENT
x# x#
Chapter 1. x# x# The Role of the Advanced Practice Nurse as Prescriber .................................................................. 4
x# x# x# x# x# x# x# x#
Chapter 2. x# x# Review of Basic Principles of Pharmacology ................................................................................... 5
x# x# x# x# x#
Chapter 3. x# x# Rational Drug Selection ................................................................................................................... 11
x# x#
Chapter 4. x# x# Legal and Professional Issues in Prescribing .................................................................................. 14
x# x# x# x# x#
Chapter 5. x# x# Adverse Drug Reactions ................................................................................................................... 16
x# x#
Chapter 6. x# x# An Introduction to Pharmacogenomics ............................................................................................ 19
x# x# x#
Chapter 7. x# x# Nutrition and Nutraceuticals............................................................................................................. 22
x# x#
Chapter 8. x# x# Herbal Therapies ............................................................................................................................... 28
x#
Chapter 9. Cannabis ............................................................................................................................................ 31
x# x#
Chapter 10.x# x# Pharmacoeconomics ........................................................................................................................ 35
Chapter 11.x# x# Drugs Affecting the Autonomic Nervous System ......................................................................... 38
x# x# x# x# x#
Chapter 12.x# x# Drugs Affecting the Central Nervous System ............................................................................... 45
x# x# x# x# x#
Chapter 13.x# x# Drugs Affecting the Cardiovascular and Renal Systems .............................................................. 53
x# x# x# x# x# x#
Chapter 14.x# x# Drugs Affecting the Respiratory System ....................................................................................... 61
x# x# x# x#
Chapter 15. Drugs Affecting the Hematological System .................................................................................. 65
x# x# x# x# x# x#
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ....................................... 69
x# x# x# x# x# x# x# x# x#
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ........................................................... 75
x# x# x# x# x# x# x#
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................ 77
x# x# x# x# x# x#
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ............... 80
x# x# x# x# x# x# x# x# x# x# x#
Chapter 20.x# x# Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs......................... 83
x# x# x# x# x# x# x# x# x#
Chapter 21.x# x# Drugs Affecting the Reproductive System .................................................................................... 86
x# x# x# x#
Chapter 22.x# x# Drugs Affecting the Bones and Joints ........................................................................................... 92
x# x# x# x# x#
Chapter 23.x# x# Drugs Affecting the Integumentary System .................................................................................. 96
x# x# x# x#
Chapter 24.x# x# Drugs Used to Treat Bacterial Infections .................................................................................... 101
x# x# x# x# x#
Chapter 25.x# x# Drugs Used to Treat Viral, Fungal, and Protozoal Infections .................................................... 105
x# x# x# x# x# x# x# x#
Chapter 26.x# x# Drugs Used to Treat Inflammatory Processes ............................................................................. 108
x# x# x# x# x#
Chapter 27.x# x# Drugs Used to Treat Eye and Ear Disorders ............................................................................... 111
x# x# x# x# x# x# x#
Chapter 28.x# x# Anemia .......................................................................................................................................... 113
Chapter 29.x# x# Anxiety and Depression ............................................................................................................... 116
x# x#
Chapter 30.x# x# Attention Deficit-Hyperactivity Disorder .................................................................................... 120
x# x#
Chapter 31.x# x# Asthma and Allergy ..................................................................................................................... 122
x# x#
Chapter 32.x# x# Chronic Obstructive Pulmonary Disease ..................................................................................... 125
x# x# x#
Chapter 33.x# x# Contraception ................................................................................................................................ 127
Chapter 34.x# x# COVID-19: Acute and Chronic ................................................................................................... 130
x# x# x#
Chapter 35.x# x# Dermatological Conditions ........................................................................................................... 134
x#
Chapter 36. Diabetes Management .................................................................................................................. 138
x# x# x#
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease .................................................................... 146
x# x# x# x# x# x# x#
Chapter 38. Headaches ..................................................................................................................................... 149
x# x#
Chapter 39. Heart Failure ................................................................................................................................. 153
x# x# x#
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome.......................................................... 158
x# x# x# x# x# x# x#
Chapter 41. Menopausal Hormone Therapy .................................................................................................... 161
x# x# x# x#
,Chapter 42. Hyperlipidemia.............................................................................................................................. 164
x# x#
Chapter 43. Hypertension ................................................................................................................................. 169
x# x#
Chapter 44. Hyperthyroidism and Hypothyroidism ......................................................................................... 174
x# x# x# x#
Chapter 45. Obesity .......................................................................................................................................... 177
x# x#
Chapter 46. Pain Management: Acute and Chronic Pain................................................................................ 181
x# x# x# x# x# x# x#
Chapter 47. Pneumonia..................................................................................................................................... 185
x# x#
Chapter 48. Sexually Transmitted Diseases and Vaginitis .............................................................................. 187
x# x# x# x# x# x#
Chapter 49. Substance Use Disorders .............................................................................................................. 190
x# x# x# x#
Chapter 50. Tuberculosis .................................................................................................................................. 195
x# x#
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...... 197
x# x# x# x# x# x# x# x# x# x# x# x#
Chapter 52. Urinary Tract Infections ............................................................................................................... 200
x# x# x# x#
Chapter 53. Women as Patients ....................................................................................................................... 203
x# x# x# x#
Chapter 54. Men as Patients............................................................................................................................. 207
x# x# x# x#
Chapter 55. Pediatric Patients .......................................................................................................................... 209
x# x# x#
Chapter 57. Geriatric Patients .......................................................................................................................... 213
x# x# x#
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 x# x# x# x# Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
x# x# x# x# x# x# x# x# x# x#
MULTIPLE CHOICE x#
1. Nurse practitioner prescriptive authority is regulated by:
x# x# x# x# x# x#
A. The National Council of State Boards of Nursing
x# x# x# x# x# x# x#
B. The U.S. Drug Enforcement Administration
x# x# x# x#
C. The State Board of Nursing for each state
x# x# x# x# x# x# x#
D. The State Board of Pharmacy
x# x# x# x#
ANS: x # C PTS: x # x # 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescrib
x# x# x# x# x# x# x# x# x# x# x# x# x#
er include:
x#
A. Nurses know more about pharmacology than other prescribers because they take
x# x# x# x# x# x# x# x# x# x# x#
it both in their basic nursing program and in their APRN program.
x# x# x# x# x# x# x# x# x# x# x#
B. Nurses care for the patient from a holistic approach and include the patient i
x# x# x# x# x# x# x# x# x# x# x# x# x#
n decision-making regarding their care.
x# x# x# x#
C. APRNs are less likely to prescribe narcotics and other controlled substances.
x# x# x# x# x# x# x# x# x# x#
D. APRNs are able to prescribe independently in all states, whereas a physician’
x# x# x# x# x# x# x# x# x# x# x#
s assistant needs to have a physician supervising their practice.
x# x# x# x# x# x# x# x# x#
ANS: x # B PTS: x # x # 1
3. Clinical judgment in prescribing includes:
x# x# x# x#
A. Factoring in the cost to the patient of the medication prescribed
x# x# x# x# x# x# x# x# x# x#
B. Always prescribing the newest medication available for the disease process
x# x# x# x# x# x# x# x# x#
C. Handing out drug samples to poor patients
x# x# x# x# x# x#
D. Prescribing all generic medications to cut costs x# x# x# x# x# x#
ANS: x # A PTS: x # x # 1
4. The process for choosing an effective drug for a disorder includes:
x# x# x# x# x# x# x# x# x# x#
A. Asking the patient what drug they think would work best for them
x# x# x# x# x# x# x# x# x# x# x#
B. Consulting nationally recognized guidelines for disease management
x# x# x# x# x# x#
C. Prescribing medications that are available as samples before writing a prescription
x# x# x# x# x# x# x# x# x# x#
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
x# x# x# x# x# x# x#
ANS: x # B PTS: x # x # 1
5. Nonintentional nonadherence of drug therapy may occur due to:
x# x# x# x# x# x# x# x#
A. Belief that medication does not work
x# x# x# x# x#
B. Adverse drug reactions x# x#
C. Chronic conditions that require daily therapy
x# x# x# x# x#
D. Forgetfulness or distraction x# x#
ANS: x # D PTS: x # x # 1
